Audit Trail Review DMEG Update – New Guide
Date: October 16, 2024
The Audit Trail Review (ATR) DMEG has been hard at work putting the finishing touches on a paper around ATR, titled Getting started with Audit Trail Review in Clinical Trial data: An Essential Guide.
This guide draws on our combined understanding and knowledge of this complex process. The goal of the paper is to demystify the implementation of an ATR process for clinical trial data, outlining the essential aspects, with suggestions and recommendations for how organisations can get started with this process. We share examples of findings and operational insights into the process, discuss CRO and Vendor perspectives, and conclude with thoughts on future directions in the ATR space.
We are pleased to share that the paper can now be read on our ATR DMEG page. Click here to find out more about our work and view the paper.
– Jennifer Nielsen, ATR DMEG Chair
Explore More News
Launch of Online Training from ACDM
The Association for Clinical Data Management is delighted to announce the launch of Online . . .
Read More
ACDM 2019 Awards Finalists
The Association for Clinical Data Management are delighted to announce the finalists for . . .
Read More
Castor EDC to Sponsor ACDM19
The Association for Clinical Data Management (ACDM) are delighted to announce that Castor . . .
Read More
Danone Nutricia Research to Sponsor ACDM19
The Association for Clinical Data Management (ACDM) are delighted to announce that . . .
Read More
ACDM19 Conference Programme
The Association for Clinical Data Management is delighted to announce the Full Programme . . .
Read More
Record Number of Abstracts Submitted for ACDM19
The deadline for Abstracts for ACDM19 passed on the 30th September and the Association for . . .
Read More
Phastar Sponsor ACDM19
The Association for Clinical Data Management are delighted to announce that PHASTAR are . . .
Read More
Launch of Annual ACDM Awards
The Association for Clinical Data Management are delighted to announce the introduction of . . .
Read More
